Biologically active lasonolide compounds

Details Biologically active lasonolide compounds Biologically active lasonolide compounds

2006-10-03

2006-10-03

McKenzie, Thomas (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

active

07115756

ABSTRACT:
The subject invention provides novel compositions of biologically active macrolide compounds which can advantageously be used in blocking cellular proliferation, treatment of cancer, treatment of fungal infections and control of spoilage of food, cosmetic and other consumer items.

REFERENCES:
patent: 5478861 (1995-12-01), Horton et al.
patent: 5684036 (1997-11-01), Horton et al.
patent: 5869038 (1999-02-01), Leifert et al.
patent: 6476065 (2002-11-01), Gunasekera et al.
Sugawara, I., Multidrug Resistance: Role of Multidrug Resistance-Associated Protein (MRP),The Cancer Journal, 8(2) 1995.
Barrand, M., Bagrij, T., and Neo, S., Multidrug Resistance—Associated Protein: A Protein Distance from P-glycoprotein Involved in Cytotoxic Drug Expulsion, General Pharmacology (1997), 28 (5): 639-645.
Bellamy, W. T., P-glycoproteins and Multidrug Resistance, Annu. Rev. Pharmacol. Toxicol. (1996), 36: 161-183.
Broxterman, H. J., Giaccone, G., and Lankelma, J., Multidrug resistance proteins and other drug transport-related resistance to natural product agents, Current Opinion in Oncology (1995), 7:532-540.
Casazza, A. M. and C. R. Fairchild (1996) “Paclitaxel (Taxol®): mechanisms of resistance”Cancer Treat Res.87:149-171.
Komarov, P. G., Shtil, A. A., Holian, O. Tee, L., Buckingham, L., Mechetner, E. B., Roninson, I. B., and Coon, J. S., Activation of theLRP(Lung Resistance-Related Protein) Gene by Short-Term Exposure of Human Leukemia Cells to Phorbol Ester and Cytarabine, Oncology Research (1998), 10:185-192.
Krishan, A., Fitz, C. M., and Andritsch, I., Drug Retention, Efflux, and Resistance in Tumor Cells, Cytometry (1997), 29:279-285.
Kruh, G. D., Gaughan, K. T., Godwin, A., and Chan, A., Expression Pattern of MRP in Human Tissues and Adult Solid Tumor Cell Lines, Journal of the National Cancer Institute (1995), 87 (16): 1256-1258.
Miller, D. W., Fontain, M., Kolar, C., and Lawson, T., The expression of multidrug resistance-associated protein (MRP) in pancreatic adenocarcinoma cell lines, Cancer Letters (1996), 107:301-306.

Affiliated with

Also associated with

Rating

Biologically active lasonolide compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biologically active lasonolide compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biologically active lasonolide compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3699341